Technical Analysis for DYN - Dyne Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 23.65 | -4.71% | -1.17 |
DYN closed down 4.71 percent on Thursday, April 18, 2024, on 71 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | -4.71% | |
| Gapped Up | Strength | -4.71% | |
| Lower Bollinger Band Touch | Weakness | -4.71% | |
| Oversold Stochastic | Weakness | -4.71% | |
| 50 DMA Resistance | Bearish | -3.98% |
| Alert | Time |
|---|---|
| Down 3% | about 9 hours ago |
| Fell Below Lower Bollinger Band | about 9 hours ago |
| 60 Minute Opening Range Breakdown | about 9 hours ago |
| Outside Day | about 11 hours ago |
| Fell Below Previous Day's Low | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 30.2687 |
| 52 Week Low | 6.4 |
| Average Volume | 1,378,280 |
| 200-Day Moving Average | 15.16 |
| 50-Day Moving Average | 25.85 |
| 20-Day Moving Average | 26.87 |
| 10-Day Moving Average | 25.92 |
| Average True Range | 1.66 |
| RSI (14) | 38.27 |
| ADX | 20.88 |
| +DI | 15.47 |
| -DI | 27.04 |
| Chandelier Exit (Long, 3 ATRs) | 24.82 |
| Chandelier Exit (Short, 3 ATRs) | 28.52 |
| Upper Bollinger Bands | 29.77 |
| Lower Bollinger Band | 23.97 |
| Percent B (%b) | -0.05 |
| BandWidth | 21.59 |
| MACD Line | -0.33 |
| MACD Signal Line | 0.21 |
| MACD Histogram | -0.5345 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.28 | ||||
| Resistance 3 (R3) | 26.53 | 25.91 | 25.84 | ||
| Resistance 2 (R2) | 25.91 | 25.24 | 25.78 | 25.69 | |
| Resistance 1 (R1) | 24.78 | 24.83 | 24.47 | 24.53 | 25.55 |
| Pivot Point | 24.16 | 24.16 | 24.01 | 24.03 | 24.16 |
| Support 1 (S1) | 23.03 | 23.49 | 22.72 | 22.78 | 21.75 |
| Support 2 (S2) | 22.41 | 23.08 | 22.28 | 21.61 | |
| Support 3 (S3) | 21.28 | 22.41 | 21.46 | ||
| Support 4 (S4) | 21.03 |
